Cargando…
Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair
Although receptor-activator of nuclear factor κB (RANK), its ligand RANKL, and osteoprotegerin (OPG), which are members of the tumor necrosis factor (TNF) superfamily, were first discovered in bone cells, they are also expressed in other cells, including skeletal muscle. We previously showed that th...
Autores principales: | Bouredji, Zineb, Hamoudi, Dounia, Marcadet, Laetitia, Argaw, Anteneh, Frenette, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102421/ https://www.ncbi.nlm.nih.gov/pubmed/33997104 http://dx.doi.org/10.1016/j.omtm.2021.03.022 |
Ejemplares similares
-
The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease
por: Marcadet, Laetitia, et al.
Publicado: (2022) -
Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy
por: Dufresne, Sébastien S., et al.
Publicado: (2018) -
The inflammatory response, a mixed blessing for muscle homeostasis and plasticity
por: Bouredji, Zineb, et al.
Publicado: (2022) -
RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy
por: Marcadet, Laetitia, et al.
Publicado: (2023) -
Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice
por: Boulanger Piette, Antoine, et al.
Publicado: (2018)